Erteberel

DB07933InvestigationalSmall molecule

Erteberel is an estrogen receptor beta agonist that has been used in trials studying the treatment of Benign Prostatic Hyperplasia.

Chemical structure of Erteberel
Mechanism
Curator reviewed
Formula / weight
C18H18O3 · 282.3337 g/mol (avg)
Code names
LY-500307 · SERBA-1

Resolves to

Compound
UNII2ZUL6758TZCAS533884-09-2ChEMBLCHEMBL278703PubChem10286159KEGGD09899
Structure
InChIKeyXIESSJVMWNJCGZ-VKJFTORMSA-NSMILES[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1
Targets
Q92731ESR2P03372ESR1

What you can answer from here — as of March 06, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Erteberel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In